ARTICLE | Company News
MorphoSys, University College London deal
August 9, 2010 7:00 AM UTC
The university's UCL Business plc commercialization arm granted MorphoSys' AbD Serotec unit worldwide, exclusive rights to research and diagnostic applications of an antibody against parathyroid horm...